US Stock MarketDetailed Quotes

Inhibikase Therapeutics (IKT)

Watchlist
  • 1.730
  • -0.130-6.99%
Close May 15 16:00 ET
  • 1.730
  • 0.0000.00%
Post 16:10 ET
228.42MMarket Cap-3.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibikase Therapeutics (IKT) Revenue Breakdown Overview

By Business/Source

Currency:USD
2023/FY
Stock NameRevenueRatio
Developing protein kinase inhibitor therapeutics260.5K100.00%

By Country/Region

Currency:USD
2023/FY
Stock NameRevenueRatio
United States260.5K100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -